1. Home
  2. CRBP vs HBB Comparison

CRBP vs HBB Comparison

Compare CRBP & HBB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Corbus Pharmaceuticals Holdings Inc.

CRBP

Corbus Pharmaceuticals Holdings Inc.

HOLD

Current Price

$9.69

Market Cap

202.6M

Sector

Health Care

ML Signal

HOLD

Logo Hamilton Beach Brands Holding Company

HBB

Hamilton Beach Brands Holding Company

N/A

Current Price

$16.45

Market Cap

210.8M

ML Signal

N/A

Company Overview

Basic Information
Metric
CRBP
HBB
Founded
2009
1904
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Home Furnishings
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
202.6M
210.8M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
CRBP
HBB
Price
$9.69
$16.45
Analyst Decision
Strong Buy
Analyst Count
8
0
Target Price
$50.29
N/A
AVG Volume (30 Days)
513.0K
21.5K
Earning Date
11-12-2025
11-05-2025
Dividend Yield
N/A
2.91%
EPS Growth
N/A
24.53
EPS
N/A
2.34
Revenue
N/A
$607,430,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$100.00
N/A
P/E Ratio
N/A
$7.04
Revenue Growth
N/A
N/A
52 Week Low
$4.64
$12.72
52 Week High
$20.56
$21.20

Technical Indicators

Market Signals
Indicator
CRBP
HBB
Relative Strength Index (RSI) 34.73 63.35
Support Level $9.44 $15.24
Resistance Level $11.64 $16.85
Average True Range (ATR) 0.74 0.69
MACD -0.02 0.10
Stochastic Oscillator 12.16 86.26

Price Performance

Historical Comparison
CRBP
HBB

About CRBP Corbus Pharmaceuticals Holdings Inc.

Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

About HBB Hamilton Beach Brands Holding Company

Hamilton Beach Brands Holding Co, through its subsidiaries, is engaged in consumer, commercial, and specialty small appliances and specialty retail. It designs, markets, and distributes small branded electric household and specialty housewares small appliances, as well as commercial products for restaurants, bars, and hotels. It has two operating segments Home and Commercial Products and Health.

Share on Social Networks: